COMMUNIQUÉS West-GlobeNewswire

Nexstim Plc: Decisions of the Board of Directors regarding Board Committees, approval of a financing arrangement and issuance of shares under the restricted share unit plan
28/03/2018
Company announcement, Helsinki, 28 March 2018, at 2 PM Nexstim Plc: Decisions of the Board of Directors regarding Board Committees, approval of a financing arrangement and issuance of shares under the restricted share [...]
Summit Therapeutics Selected for Emerging Science Presentation at the 2018 AAN Annual Meeting
28/03/2018
Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting Oxford, UK, and Cambridge, MA, US, 28 March [...]
Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
28/03/2018
Study Unlikely To Achieve Primary Efficacy Endpoint; DMC Recommends Discontinuation of Study No Unexpected Safety Findings Edge To Reduce Costs and Evaluate Next Steps Edge To Host Conference Call on Wednesday, March 28 [...]
Cesca Therapeutics Inc. Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting
28/03/2018
RANCHO CORDOVA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) today announced that two late-breaking abstracts involving the use of Cesca’s X-Series™ technologies for cell [...]
Aileron Therapeutics Announces Expansion of Scientific Advisory Board
28/03/2018
CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN ), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that [...]
Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting
28/03/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces that it has been selected for an Emerging Science dual oral and poster [...]
Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
28/03/2018
CALGARY, Alberta, March 28, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX ) announced today the publication of two new articles on the effect of apabetalone, a novel small [...]
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results
28/03/2018
CHARLESTON, S.C., March 28, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) today reported financial and operating results for the fourth quarter and year ended December 31, 2017. All Amounts [...]
Hiku Brands and dosist join forces in Canadian market
28/03/2018
TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU), Canada’s first vertically-integrated cannabis brand house, is pleased to announce it has entered into a letter of intent to [...]
GENFIT: Presentations at EASL 2018 Annual Congress Highlight Progress in NASH Diagnostics, Combination Therapies and Deep-learning Applications in Medical Imaging
28/03/2018
GENFIT: Presentations at EASL 2018 Annual Congress Highlight Progress in NASH Diagnostics, Combination Therapies and Deep-learning Applications in Medical Imaging Lille (France), Cambridge (Massachusetts, United States [...]
GENFIT: Les données présentées au congrès EASL ILC 2018 souligneront les avancées de la Société en matière de diagnostic de la NASH, de combinaisons de traitement, d'analyse d'images via deep-learning
28/03/2018
GENFIT: Les données présentées au congrès EASL ILC 2018 souligneront les avancées de la Société en matière de diagnostic de la NASH, de combinaisons de traitement, d'analyse d'images via deep-learning Lille (France), [...]
Hydropothecary reports fiscal 2018 second quarter results; achieves revenue visibility and business certainty for the first year following cannabis legalization
28/03/2018
GATINEAU, Quebec, March 28, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSX VENTURE:THCX) (the "Company") reported its financial results for the three and six months ended January 31, 2018, the second [...]
Hydropothecary déclare les résultats du deuxième trimestre de l’exercice 2018, démontrant la prévisibilité de ses revenus et sa certitude commerciale dès la première année suivant la légalisation du cannabis
28/03/2018
GATINEAU, Quebec, 28 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (la « Société ») a publié ses résultats financiers pour le trimestre et le semestre clos le 31 janvier 2018, à savoir le [...]
PotNetwork Holding Inc.’s Diamond CBD Releases Corporate Video Highlighting Consumer Response to its Natural Health and Wellness Products
28/03/2018
FT LAUDERDALE, Fla., March 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holding, Inc. (OTC Pink:POTN) On Wednesday, March 28th, 2018, PotNetwork Holding Inc.’s wholly owned subsidiary, Diamond CBD Inc. [...]
Assembly Biosciences Announces ABI-H0731 Phase 1b Interim Data Accepted as a Late-Breaker Poster at The International Liver Congress™ (EASL)
28/03/2018
INDIANAPOLIS and SAN FRANCISCO, March 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB ), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]
Nexstim Plc: Resolutions of the annual general meeting of shareholders, 28 March 2018
28/03/2018
Company announcement, Helsinki, 28 March 2018, at 12 PM Nexstim Plc: Resolutions of the annual general meeting of shareholders, 28 March 2018 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted [...]
Enzymatica AB: Enzymatica - publication of the annual report 2017
28/03/2018
Press release Lund, 28 march 2018 Enzymatica - publication of the annual report 2017 Enzymatica announces today that the annual report 2017 is available on the company's web site www.enzymatica.se . The annual report is [...]
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
28/03/2018
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first [...]
Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
28/03/2018
Basel, March 28, 2018 - Novartis will present new data from the HAWK and HARRIER Phase III trials at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, Honolulu, April 29 - May [...]

Pages